Hutch News

Hutch News

Stories tagged 'metastasis'

10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >


Immune cells share their insides with tumors to promote cancer spread

New study in zebrafish and mice shows immune cells interact with melanoma and transfer their contents to spur metastasis

Dec. 4, 2017 | By Rachel Tompa / Fred Hutch News Service

A new study using mice and tiny transparent fish as models of human cancer, published in Developmental Cell, has shed light on the very first stages of metastasis in the skin cancer melanoma.

View story >


Removing barriers to precision treatment of metastatic prostate cancer

GENTleMEN study aims to help men with advanced disease access genetic testing and counseling

Oct. 30, 2017 | By Sabrina Richards / Fred Hutch News Service

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 12, 2017

View story >


Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma

May 31, 2017 | By Rachel Tompa / Fred Hutch News Service

In a small, ongoing clinical trial testing a combination of three therapies, three of four patients with advanced Merkel cell carcinoma went into complete remission.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.